Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATFurniture, Fixtures and OtherLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Plus Therapeutics (PSTV) Leases (2016 - 2025)

Plus Therapeutics has reported Leases over the past 11 years, most recently at $1.8 million for Q4 2025.

  • Quarterly Leases changed 0.0% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $1.8 million for FY2025, 0.0% changed from the prior year.
  • Leases was $1.8 million for Q4 2025 at Plus Therapeutics, up from $20000.0 in the prior quarter.
  • Over five years, Leases peaked at $1.8 million in Q4 2022 and troughed at $20000.0 in Q3 2025.
  • The 5-year median for Leases is $289000.0 (2022), against an average of $641950.0.
  • Year-over-year, Leases increased 8.97% in 2022 and then crashed 81.13% in 2025.
  • A 5-year view of Leases shows it stood at $1.7 million in 2021, then increased by 8.97% to $1.8 million in 2022, then changed by 0.0% to $1.8 million in 2023, then changed by 0.0% to $1.8 million in 2024, then changed by 0.0% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Leases are $1.8 million (Q4 2025), $20000.0 (Q3 2025), and $29000.0 (Q2 2025).